8[1]Stephen K,Tyring,Istvan A,et al.a radomized,controlled molecular study of condylomata acuminate clearance during treatment with imiquimod[ J].J Infect Dis 1998;178:551.
9[2]Stanley MA.Mechanism of action of imiquimod[ J ].Papillomavirus Report,1999;10(2):23.
10[3]Miller RL,Gerster JF,Owens ML,et al.Imiquimod applied topically:a novel immune response modifier and new class of drug[J].Intern J Immunopharm,1999;21:1.
4Louise AF,Astrid N, Henrik P,et al. Muhiple flat warts asso- ciated with idiopathic CD4-positive T lymphocytopenia [J]. Journal of the American Academy of Dermatology, 2008,58 (2 Suppl) : 37-38.
5Kim MB, Ko HC,Jang HS,et al. Treatment of flat warts with 5% imiquimod cream [J]. Journal of the European Academy of Dermatology and Venereology, 2006,20 (10) : 1349-1350.
6Schon M, Schtin MP. The antitumoral mode of action of imiquimod and other imidazoquinolines [ J]. Curr Med Chem, 2007, 14 (6) : 681-687.
7Suzuki H,Wang B, Shivji GM, et al. Imiquimod,a top ical immune response modifier,induces migration of Langerhans cells [ J ]. J In- vest Dermatol, 2000, 114 ( 1 ) : 135-141.
8No authors listed. Imiquimod: new indication. Basal cell carcinoma: inferior to other treatments. Prescrire Int, 2006, 15 ( 84 ) : 130 -131.
